Cargando…

LDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies

The role of statins in preventing prostate cancer is currently a controversial issue. The aim of this review is to investigate the effects of statins use on prostate cancer risk. Electronic databases (the Cochrane Library, PubMed, Medline, Embase, Web of Science, and ClinicalTrials.gov) were searche...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Ping, Wei, Shiyou, Tang, Zhuang, Gao, Liang, Zhang, Chen, Nie, Pan, Yang, Lu, Wei, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830970/ https://www.ncbi.nlm.nih.gov/pubmed/27075437 http://dx.doi.org/10.1038/srep24521

Ejemplares similares

The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis
por: Tan, Ping, et al.
Publicado: (2016)

Oxidatively Modified LDL Suppresses Lymphangiogenesis via CD36 Signaling
por: Singla, Bhupesh, et al.
Publicado: (2021)

Bioactivity of Dietary Polyphenols: The Role in LDL-C Lowering
por: Sun, Peng, et al.
Publicado: (2021)

Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review
por: Tan, Ping, et al.
Publicado: (2017)

Effects of currently prescribed LDL-C-lowering drugs on PCSK9 and implications for the next generation of LDL-C-lowering agents
por: Konrad, Robert J, et al.
Publicado: (2011)

Oxidized LDL Induces Alternative Macrophage Phenotype through Activation of CD36 and PAFR
por: Rios, Francisco J., et al.
Publicado: (2013)

Oxidized LDL upregulates macrophage DPP4 expression via TLR4/TRIF/CD36 pathways
por: Rao, Xiaoquan, et al.
Publicado: (2019)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
por: Khan, Safi U., et al.
Publicado: (2020)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Co-Stimulation of PAFR and CD36 Is Required for oxLDL-Induced Human Macrophages Activation
por: Rios, Francisco J. O., et al.
Publicado: (2012)

Oxidized LDL/CD36 interaction induces loss of cell polarity and inhibits macrophage locomotion
por: Park, Young Mi, et al.
Publicado: (2012)

Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects
por: Ramos-Arellano, Luz E, et al.
Publicado: (2014)

meso-3,6-Dioxopiperazine-2,5-diacetamide
por: Li, Ping, et al.
Publicado: (2011)

3,6-Dichlorocatechol
por: Xie, An-Le, et al.
Publicado: (2008)

ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress
por: Yuan, Dongbo, et al.
Publicado: (2022)

Baricitinib induces LDL-C and HDL-C increases in rheumatoid arthritis: a meta-analysis of randomized controlled trials
por: Qiu, Chengfeng, et al.
Publicado: (2019)

LDL-C plays a causal role on T2DM: a Mendelian randomization analysis
por: Pan, Wenbin, et al.
Publicado: (2020)

LDL-C: lower is better for longer—even at low risk
por: Penson, Peter E., et al.
Publicado: (2020)

New and emerging lipid-modifying drugs to lower LDL cholesterol
por: Kosmas, Constantine E, et al.
Publicado: (2021)

LDL lowering effect of PCSK9 inhibition is reduced in women
por: Myasoedova, Veronika A, et al.
Publicado: (2023)

N,N′-Diisopropyl-3,6-dimethoxynaphthalene-2,7-disulfonamide
por: Song, Zu-Wei, et al.
Publicado: (2008)

Cryosurgery would be An Effective Option for Clinically Localized Prostate Cancer: A Meta-analysis and Systematic Review
por: Gao, Liang, et al.
Publicado: (2016)

3,6-diazabicyclo[3.3.1]heptanes Induces Apoptosis and Arrests Cell Cycle in Prostate Cancer Cells
por: Wei, Hongjian, et al.
Publicado: (2020)

Geophysik, 3.6
por: Rawer, Karl
Publicado: (1982)

CD36 plays an important role in the clearance of oxLDL and associated age-dependent sub-retinal deposits
por: Picard, Emilie, et al.
Publicado: (2010)

ASK1 Mediates Apoptosis and Autophagy during oxLDL-CD36 Signaling in Senescent Endothelial Cells
por: Cho, KyoungJoo, et al.
Publicado: (2019)

The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth
por: Murtola, Teemu J., et al.
Publicado: (2012)

Short-term LDL cholesterol-lowering efficacy of plant stanol esters
por: Hallikainen, Maarit, et al.
Publicado: (2002)

Unmet Needs in LDL-C Lowering: When Statins Won’t Do!
por: Krähenbühl, Stephan, et al.
Publicado: (2016)

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
por: Storey, Benjamin C., et al.
Publicado: (2018)

LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA
por: Pan, Yuesong, et al.
Publicado: (2022)

Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential
por: Deng, Chang-Feng, et al.
Publicado: (2022)

(3,6-Dibromo-o-phenylene)dimethanol
por: Li, Qi, et al.
Publicado: (2011)

Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study
por: Komiya, Ichiro, et al.
Publicado: (2021)

Association Between Baseline, Achieved, and Reduction of CRP and Cardiovascular Outcomes After LDL Cholesterol Lowering with Statins or Ezetimibe: A Systematic Review and Meta‐Analysis
por: Zhang, Xin‐Lin, et al.
Publicado: (2019)

Reduction of Connexin36 Content by ICER-1 Contributes to Insulin-Secreting Cells Apoptosis Induced by Oxidized LDL Particles
por: Haefliger, Jacques-Antoine, et al.
Publicado: (2013)

Uptake of oxLDL and IL-10 Production by Macrophages Requires PAFR and CD36 Recruitment into the Same Lipid Rafts
por: Rios, Francisco J. O., et al.
Publicado: (2013)

Alphataxin, an Orally Available Small Molecule, Decreases LDL Levels in Mice as a Surrogate for the LDL-Lowering Activity of Alpha-1 Antitrypsin in Humans
por: Bristow, Cynthia L., et al.
Publicado: (2021)

LDL-Cholesterol Lowering of Plant Sterols and Stanols—Which Factors Influence Their Efficacy?
por: Trautwein, Elke A., et al.
Publicado: (2018)

Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual Risk
por: Rikhi, Rishi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v2smr9rj2udvph3l2jjus7t5eo